Experimental treatment with ticagrelor monotherapy benefits non-obese ACS patients

2020.02.24

A subgroup analysis of a large, multicentre, randomized controlled trial has demonstrated a beneficial effect of ticagrelor monotherapy in non-obese acute coronary syndrome (ACS) patients.The GLOBAL...


Chinese researchers predict the risk of new-onset ACS in patients with diabetes

2020.02.21

Researchers have developed a potent risk predictive model to predict the probability of new-onset acute coronary syndrome (ACS) in patients with type 2 diabetes mellitus (T2DM), using data from the...